One of the biggest stories of the year has been the rise of AI in every industry. This trend will hit biotech stocks no less than any others.
Already, cutting edge healthcare stocks are getting into the AI boom. Medical science has much to gain from AI innovation. AI is bringing the ability to test and study drugs in ways never thought possible.
The best cutting-edge healthcare companies have a long history of using machine learning to quicken drug development. And AI is just the next stage of machine learning. So, for an investor who wants to gain from the inevitable future of AI in biotech stocks, explore three transformative stocks to buy this year.
This post appeared first on InvestorPlace.